Skip to main content

Table 2 Application of different FGFs in non-critical-sized bone defect in vivo models

From: Role of fibroblast growth factors in bone regeneration

Growth factor

Dose

In vivo model

Carrier

Investigations

Effect

References

FGF2

200 μg

Monkey ulna fracture

Injectable gelatin hydrogel

Bone mineral content and mechanical properties

Accelerates fracture healing and prevents nonunion

[67]

FGF2

2.5 μg

Rat periodontal defect (2 × 2 × 1.7 mm)

Injectable calcium phosphate cement

Histology and histomorphometry of bone

Increased periodontal regeneration

[68]

FGF2

50 μg

Rat calvarial defect (4-mm diameter)

PLGA/β-TCP

Histomorphometry of bone

Enhanced bone regeneration

[69]

FGF2

50 μg/ml

Rat calvarial defect (5-mm diameter)

Collagen and nano-bioactive glass hybrid membrane

Histomorphometry of bone

Accelerated bone regeneration

[70]

FGF2

45 μg

Rabbit femoral condyle (4-mm diameter and 6 mm long)

Hydrogel polymer

Bone mass and microarchitecture

Enhanced bone regeneration

[32]

FGF2

10 μg

Rat tibia (2-mm diameter, 4 mm long)

Titanium implant

Bone histomorphometry

Synergistically enhanced new bone formation

[71]

Melatonin

100 mg/kg i.p.

FGF2

200, 400, or 800 μg

Human tibia (high tibial osteotomy)

Gelatin hydrogel

Radiographic assessment of bone

Dose dependently accelerated bone union

[72]

FGF2

100 μg

Rabbit femoral condyle (10 mm2 × 5 mm depth)

Interconnected porous calcium hydroxyapatite ceramic

Bone histomorphometry

Decreases lamellar bone formation, increases vascularization and osseointegration

[73]

FGF2

0, 25, or 250 ng

Rat calvarial defect (3.5-mm diameter)

PLGA/gelatin

Radiological, histological, and biochemical examination

Low-dose administration enhanced the degree of calcification and ALP activity

[74]

BMP2

0.1 mg/ml

FGF9

2 μg

Mouse tibia (1-mm defect)

Collagen sponge

Bone histomorphometry

Enhances angiogenesis and bone regeneration

[19]

  1. The table shows the various growth factors and their combinations used for regeneration of non-critical-sized defects, their dose, the site of application, the carrier used for the application, and the investigations through which the effects of bone healing have been studied
  2. i.p. intraperitoneal injection